Home � News From UNITED STATES � News From Healthcare and Medical
Gileads investigational single-tablet regimen of bictegravir and lenacapavir for hiv treatment meets primary endpoint in phase 3 artistry-2 trial in UNITED STATES
| TI Ref No: | 526256668 |
| Date : | 16 Dec 2025 |
| Description: | Gileads investigational single-tablet regimen of bictegravir and lenacapavir for hiv treatment meets primary endpoint in phase 3 artistry-2 trial, UNITED STATES |
| Document Type | Procurement News |
|
Click Here For Login If you are registered member, kindly login to view full details of this tender notice. |
|
|
Subscribe Now If you are not a subscriber, kindly contact nikhil.j@tendersinfo.com OR Naorm@export.gov.il |